OABI - OmniAb Inc
IEX Last Trade
4.19
-0.080 -1.909%
Share volume: 427,837
Last Updated: Fri 30 Aug 2024 09:59:59 PM CEST
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) :
0.87%
PREVIOUS CLOSE
CHG
CHG%
$4.27
-0.08
-1.87%
View ratios
| Fiscal Date | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | |
|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | |
| Report Date | 2023-05-11 | 2023-08-10 | 2023-11-09 | 2024-03-25 | 2024-05-09 | |
| Total revenue | 16.919 M | 6.946 M | 5.477 M | 4.822 M | 3.801 M | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Gross profit | 16.919 M | 6.946 M | 5.477 M | 4.822 M | 3.801 M | |
| -58.95% | -21.15% | -11.96% | -21.17% | |||
| Operating expenses | 21.954 M | 22.871 M | 22.378 M | 22.635 M | 22.888 M | |
| Selling general and admin | 8.195 M | 8.738 M | 8.511 M | 7.869 M | 8.337 M | |
| Research and development | 13.759 M | 14.133 M | 13.867 M | 14.766 M | 14.551 M | |
| Total expenses | 25.372 M | 26.391 M | 25.792 M | 25.837 M | 26.354 M | |
| 4.02% | -2.27% | 0.17% | 2.00% | |||
| Operating income | -8.453 M | -19.445 M | -20.315 M | -21.015 M | -22.553 M | |
| Ebit | -8.453 M | -19.445 M | -20.315 M | -21.206 M | -22.553 M | |
| Pretax income | -7.129 M | -18.164 M | -19.042 M | -20.028 M | -21.578 M | |
| 154.79% | 4.83% | 5.18% | 7.74% | |||
| Income tax | -1.029 M | -3.436 M | -3.304 M | -5.975 M | -2.617 M | |
| Net income basic | -6.100 M | -14.728 M | -15.738 M | -14.053 M | -18.961 M | |
| -141.44% | -6.86% | 10.71% | -34.92% | |||
| Net income | -6.100 M | -14.728 M | -15.738 M | -14.053 M | -18.961 M | |
| -141.44% | -6.86% | 10.71% | -34.92% |